UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000017904 |
|---|---|
| Receipt number | R000020741 |
| Scientific Title | Retrospective study for prediction of glaucoma progression |
| Date of disclosure of the study information | 2015/06/16 |
| Last modified on | 2020/12/25 17:51:22 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Retrospective study for prediction of glaucoma progression
Acronym
Retrospective study for prediction of glaucoma progression
Scientific Title
Retrospective study for prediction of glaucoma progression
Scientific Title:Acronym
Retrospective study for prediction of glaucoma progression
Region
| Japan |
Condition
Condition
Glaucoma
Classification by specialty
| Ophthalmology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To investigate prediction of glaucoma progression in Japanese patients
Basic objectives2
Others
Basic objectives -Others
Progression of visual field loss
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Progression of visual field loss
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients who visit Fukuiken Saiseikai Hospital during the survey period
Key exclusion criteria
Not applicable
Target sample size
300
Research contact person
Name of lead principal investigator
| 1st name | Koji |
| Middle name | |
| Last name | Nitta |
Organization
Fukuiken Saiseikai Hospital
Division name
Ophthalmology
Zip code
918-8503
Address
Funabashi 7-1, Wadanaka-cho, Fukui City, Fukui
TEL
0776-23-1111
k-nitta@fukui.saiseikai.or.jp
Public contact
Name of contact person
| 1st name | Koji |
| Middle name | |
| Last name | Nitta |
Organization
Fukuiken Saiseikai Hospital
Division name
Ophthalmology
Zip code
918-8503
Address
Funabashi 7-1, Wadanaka-cho, Fukui City, Fukui
TEL
0776-23-1111
Homepage URL
k-nitta@fukui.saiseikai.or.jp
Sponsor or person
Institute
Fukuiken Saiseikai Hospital
Institute
Department
Personal name
Funding Source
Organization
Santen Pharmaceutical Co.,Ltd.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Fukuiken Saiseikai Hospital
Address
Funabashi 7-1, Wadanaka-cho, Fukui City, Fukui
Tel
0776-23-1111
somuka@fukui.saiseikai.or.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
福井県済生会病院(福井県)/ Fukuiken Saiseikai Hospital(Fukui Pref.)
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 06 | Month | 16 | Day |
Related information
URL releasing protocol
Not applicable
Publication of results
Published
Result
URL related to results and publications
https://www.nature.com/articles/s41598-017-15267-y , https://doi.org/10.2147/OPTH.S247618
Number of participants that the trial has enrolled
312
Results
Refer to published paper
Results date posted
| 2020 | Year | 12 | Month | 25 | Day |
Results Delayed
Results Delay Reason
Date of the first journal publication of results
| 2017 | Year | 11 | Month | 08 | Day |
Baseline Characteristics
Refer to published paper
Participant flow
Refer to published paper
Adverse events
Refer to published paper
Outcome measures
Refer to published paper
Plan to share IPD
The datasets are not publicly available, but are available from the corresponding author on reasonable request.
IPD sharing Plan description
The datasets are not publicly available, but are available from the corresponding author on reasonable request.
Progress
Recruitment status
Completed
Date of protocol fixation
| 2015 | Year | 05 | Month | 18 | Day |
Date of IRB
| 2015 | Year | 05 | Month | 18 | Day |
Anticipated trial start date
| 2015 | Year | 05 | Month | 26 | Day |
Last follow-up date
| 2015 | Year | 10 | Month | 07 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Retrospective study
Prediction of Glaucoma progression
Target sample size : No. of the target patients during the survey period
Management information
Registered date
| 2015 | Year | 06 | Month | 15 | Day |
Last modified on
| 2020 | Year | 12 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020741
